Lasso Peptide Microcin J25 Effectively Enhances Gut Barrier Function and Modulates Inflammatory Response in an Enterotoxigenic <i>Escherichia coli</i>-Challenged Mouse Model

Bacterial resistance leads to severe public health and safety issues worldwide. Alternatives to antibiotics are currently needed. A promising lasso peptide, microcin J25 (MccJ25), is considered to be the best potential substitute for antibiotics to treat pathogen infection, including enterotoxigenic...

Full description

Bibliographic Details
Main Authors: Xiuliang Ding, Haitao Yu, Shiyan Qiao
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/18/6500
_version_ 1797554464938262528
author Xiuliang Ding
Haitao Yu
Shiyan Qiao
author_facet Xiuliang Ding
Haitao Yu
Shiyan Qiao
author_sort Xiuliang Ding
collection DOAJ
description Bacterial resistance leads to severe public health and safety issues worldwide. Alternatives to antibiotics are currently needed. A promising lasso peptide, microcin J25 (MccJ25), is considered to be the best potential substitute for antibiotics to treat pathogen infection, including enterotoxigenic <i>Escherichia coli</i> (ETEC). This study evaluated the efficacy of MccJ25 in the prevention of ETEC infection. Forty-five female BALB/c mice of clean grade (aged seven weeks, approximately 16.15 g) were randomly divided into three experimental groups as follows: (i) control group (uninfected); (ii) ETEC infection group; (iii) MccJ25 + ETEC group. Fifteen mice per group in five cages, three mice/cage. MccJ25 conferred effective protection against ETEC-induced body weight loss, decrease in rectal temperature and increase in diarrhea scores in mice. Moreover, in ETEC-challenged mice model, MccJ25 significantly improved intestinal morphology, decreased intestinal histopathological scores and attenuated intestinal inflammation by decreasing proinflammatory cytokines and intestinal permeability, including reducing serum diamine oxidase and D-lactate levels. MccJ25 enhanced epithelial barrier function by increasing occludin expression in the colon and claudin-1 expression in the jejunum, ultimately improving intestinal health of host. MccJ25 was further found to alleviate gut inflammatory responses by decreasing inflammatory cytokine production and expression via the activation of the mitogen-activated protein kinase and nuclear factor κB signaling pathways. Taken together, the results indicated that MccJ25 protects against ETEC-induced intestinal injury and intestinal inflammatory responses, suggesting the potential application of MccJ25 as an excellent antimicrobial or anti-inflammation agent against pathogen infections.
first_indexed 2024-03-10T16:32:27Z
format Article
id doaj.art-096e56250db54d578873eea217bceaed
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T16:32:27Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-096e56250db54d578873eea217bceaed2023-11-20T12:42:05ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-09-012118650010.3390/ijms21186500Lasso Peptide Microcin J25 Effectively Enhances Gut Barrier Function and Modulates Inflammatory Response in an Enterotoxigenic <i>Escherichia coli</i>-Challenged Mouse ModelXiuliang Ding0Haitao Yu1Shiyan Qiao2State Key Laboratory of Animal Nutrition, Ministry of Agriculture Feed Industry Center, China Agricultural University, Beijing 100193, ChinaState Key Laboratory of Animal Nutrition, Ministry of Agriculture Feed Industry Center, China Agricultural University, Beijing 100193, ChinaState Key Laboratory of Animal Nutrition, Ministry of Agriculture Feed Industry Center, China Agricultural University, Beijing 100193, ChinaBacterial resistance leads to severe public health and safety issues worldwide. Alternatives to antibiotics are currently needed. A promising lasso peptide, microcin J25 (MccJ25), is considered to be the best potential substitute for antibiotics to treat pathogen infection, including enterotoxigenic <i>Escherichia coli</i> (ETEC). This study evaluated the efficacy of MccJ25 in the prevention of ETEC infection. Forty-five female BALB/c mice of clean grade (aged seven weeks, approximately 16.15 g) were randomly divided into three experimental groups as follows: (i) control group (uninfected); (ii) ETEC infection group; (iii) MccJ25 + ETEC group. Fifteen mice per group in five cages, three mice/cage. MccJ25 conferred effective protection against ETEC-induced body weight loss, decrease in rectal temperature and increase in diarrhea scores in mice. Moreover, in ETEC-challenged mice model, MccJ25 significantly improved intestinal morphology, decreased intestinal histopathological scores and attenuated intestinal inflammation by decreasing proinflammatory cytokines and intestinal permeability, including reducing serum diamine oxidase and D-lactate levels. MccJ25 enhanced epithelial barrier function by increasing occludin expression in the colon and claudin-1 expression in the jejunum, ultimately improving intestinal health of host. MccJ25 was further found to alleviate gut inflammatory responses by decreasing inflammatory cytokine production and expression via the activation of the mitogen-activated protein kinase and nuclear factor κB signaling pathways. Taken together, the results indicated that MccJ25 protects against ETEC-induced intestinal injury and intestinal inflammatory responses, suggesting the potential application of MccJ25 as an excellent antimicrobial or anti-inflammation agent against pathogen infections.https://www.mdpi.com/1422-0067/21/18/6500enterotoxigenic <i>Escherichia coli</i>microcin J25intestinal epithelial barrierintestinal inflammationmicepathogen
spellingShingle Xiuliang Ding
Haitao Yu
Shiyan Qiao
Lasso Peptide Microcin J25 Effectively Enhances Gut Barrier Function and Modulates Inflammatory Response in an Enterotoxigenic <i>Escherichia coli</i>-Challenged Mouse Model
International Journal of Molecular Sciences
enterotoxigenic <i>Escherichia coli</i>
microcin J25
intestinal epithelial barrier
intestinal inflammation
mice
pathogen
title Lasso Peptide Microcin J25 Effectively Enhances Gut Barrier Function and Modulates Inflammatory Response in an Enterotoxigenic <i>Escherichia coli</i>-Challenged Mouse Model
title_full Lasso Peptide Microcin J25 Effectively Enhances Gut Barrier Function and Modulates Inflammatory Response in an Enterotoxigenic <i>Escherichia coli</i>-Challenged Mouse Model
title_fullStr Lasso Peptide Microcin J25 Effectively Enhances Gut Barrier Function and Modulates Inflammatory Response in an Enterotoxigenic <i>Escherichia coli</i>-Challenged Mouse Model
title_full_unstemmed Lasso Peptide Microcin J25 Effectively Enhances Gut Barrier Function and Modulates Inflammatory Response in an Enterotoxigenic <i>Escherichia coli</i>-Challenged Mouse Model
title_short Lasso Peptide Microcin J25 Effectively Enhances Gut Barrier Function and Modulates Inflammatory Response in an Enterotoxigenic <i>Escherichia coli</i>-Challenged Mouse Model
title_sort lasso peptide microcin j25 effectively enhances gut barrier function and modulates inflammatory response in an enterotoxigenic i escherichia coli i challenged mouse model
topic enterotoxigenic <i>Escherichia coli</i>
microcin J25
intestinal epithelial barrier
intestinal inflammation
mice
pathogen
url https://www.mdpi.com/1422-0067/21/18/6500
work_keys_str_mv AT xiuliangding lassopeptidemicrocinj25effectivelyenhancesgutbarrierfunctionandmodulatesinflammatoryresponseinanenterotoxigeniciescherichiacoliichallengedmousemodel
AT haitaoyu lassopeptidemicrocinj25effectivelyenhancesgutbarrierfunctionandmodulatesinflammatoryresponseinanenterotoxigeniciescherichiacoliichallengedmousemodel
AT shiyanqiao lassopeptidemicrocinj25effectivelyenhancesgutbarrierfunctionandmodulatesinflammatoryresponseinanenterotoxigeniciescherichiacoliichallengedmousemodel